Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

NCT01364064 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1153

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: TMZ

Sponsor

King Faisal Specialist Hospital & Research Center

Collaborators

[object Object]